A single DNA letter, inserted into a stretch of the genome that doesn’t code for any protein, was enough to turn genetically female mouse embryos into anatomically male mice. The experiment, published in Nature Communications in April 2026 by a team at Bar-Ilan University in Israel, is the clearest demonstration yet that a tiny tweak in a regulatory region can completely override chromosomal sex in a mammal.
The target was a distant genetic switch called Enh13, an enhancer element located roughly 557,000 base pairs upstream of the Sox9 gene. Sox9 is the master trigger for testis formation during embryonic development. Enh13 doesn’t produce a protein itself. Instead, it acts like a remote volume knob, controlling how much Sox9 protein the developing gonad makes during a narrow window when the embryo commits to a male or female path.
Using CRISPR-based genome editing, the Bar-Ilan researchers inserted a single base pair into Enh13 in XX (genetically female) mouse embryos. That one-letter change was sufficient to push Sox9 expression above the threshold for male development. The resulting mice developed testes, male internal reproductive structures, and male external genitalia, despite carrying two X chromosomes and no Y.
A mirror image of the 2018 discovery
The new result is the inverse of a landmark finding from 2018. In that earlier study, researchers at the Francis Crick Institute in London deleted Enh13 from XY male mice and observed the animals developing ovaries and female anatomy. Removing the enhancer dropped Sox9 levels below the male threshold, so genetically male embryos defaulted to the female developmental program.
Together, the two experiments bracket the same mechanism from opposite directions. Delete the enhancer in males and you get females. Insert a single nucleotide in the enhancer in females and you get males. The symmetry underscores how finely balanced mammalian sex determination really is, and how much power a noncoding regulatory element holds over the outcome.
A subsequent study in Nucleic Acids Research added further detail, reporting that Enh13 contains two redundant transcription-factor binding sites, each independently essential for normal sex determination. The enhancer’s internal architecture, in other words, is precisely tuned. The April 2026 single-nucleotide result confirms that even the smallest disruption at this locus can produce an all-or-nothing shift in sexual development.
Why it matters for human medicine
The mouse findings have direct relevance to human biology. A separate 2018 study, also published in Nature Communications, documented that duplications or deletions of enhancer regions upstream of the human SOX9 gene cause sex reversal and disorders of sex development (DSD) in patients. The mouse Enh13 region corresponds to one of those human regulatory intervals, meaning the mechanism is conserved across species.
For clinicians evaluating patients with unexplained DSD, the practical implication is significant. Standard exome sequencing reads only protein-coding DNA and would miss a single-nucleotide variant buried in a distant enhancer. The Bar-Ilan work points to a specific noncoding region that diagnostic pipelines may need to cover. When exome or gene-panel testing fails to explain a DSD case, targeted sequencing of the SOX9 regulatory landscape, including the human equivalent of Enh13, could reveal hidden pathogenic variants.
What remains uncertain
Several important questions are still open. The April 2026 Nature Communications paper does not describe whether the sex-reversed XX male mice are fertile or whether they develop normally through adulthood. Gonadal sex reversal does not guarantee functional sperm production, and long-term health outcomes have not been reported in that study or in any subsequent publication as of May 2026.
The human translation is also incomplete. While structural variants near SOX9 have been linked to DSD in patients, no clinical case has yet tied a single-nucleotide change in the Enh13-equivalent human enhancer to sex reversal in a specific individual. The inference from mouse to human rests on conserved genomic architecture and association data, not on direct confirmation in affected families.
Penetrance is another open question. In the controlled setting of inbred laboratory mice, the single-base insertion produced complete reversal every time. But sex determination in mammals sits on a threshold, and genetic background matters. In genetically diverse human populations, variation in other sex-determining genes could buffer or amplify the effect of a single enhancer mutation, potentially producing partial or ambiguous outcomes rather than full reversal.
Independent coverage in Nature noted the conceptual importance of the result while flagging these same gaps: fertility data, long-term health, and direct human evidence are all still needed.
The bigger picture
Biologists have long known that the genome’s vast noncoding regions, once dismissed as “junk DNA,” contain regulatory elements that govern when, where, and how much genes are expressed. The Bar-Ilan experiment offers one of the most dramatic illustrations of that principle to date. A single base pair in a region with no protein-coding function was enough to override the entire chromosomal sex of an organism.
The work also reframes how researchers think about the robustness of biological sex. Mammalian sex determination is resilient under normal conditions, but it depends on a finely balanced network of genes and enhancers. At key control points like Enh13, the margin between male and female development can be astonishingly thin.
For now, the most responsible reading of the evidence is that this is a compelling model for what can happen, not yet a confirmed account of what does happen in people. As researchers gather fertility data, screen human DSD cohorts for analogous variants, and test candidate mutations in functional assays, the picture will sharpen. But the core finding already stands on solid ground: in mice, one letter of noncoding DNA is enough to rewrite sex.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
